Mylan Laboratories Limited Dolutegravir Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Dolutegravir Export Records India — #11 Exporter, 110 Shipments, $5.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Dolutegravir

India Pharmaceutical Trade Intelligence

$4.2B104 Suppliers145 CountriesHS 30049099

ExportsIndia → BOTSWANA75.3%India → TANZANIA6.1%

ImportsCANADA → India$1.0M UNITED STATES → India$970.9K

#1 Buyer: AFRICURE PHARMACEUTICALS

Mylan Laboratories Limited — Dolutegravir Exporter #11 | $5.5M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Dolutegravir Exporter Profile

Indian Pharmaceutical Exporter · #11 for Dolutegravir · $5.5M export value · DGFT Verified

Mylan Laboratories Limited is the #11 Indian exporter of Dolutegravir with $5.5M in export value and 110 verified shipments. Mylan Laboratories Limited holds a 3.3% market share in Dolutegravir exports across 20 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Dolutegravir Export Profile: Buyers & Destinations

Mylan Laboratories Limited Dolutegravir export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Dolutegravir?

Country	Value	Shipments	Share
SOUTH AFRICA	$2.5M	56	75.3%
GHANA	$100.0K	2	3.0%
CONGO	$100.0K	2	3.0%
CONGO (KINSHASA)	$100.0K	2	3.0%
SIERRA LEONE	$100.0K	2

Who Are the Top Buyers of Dolutegravir from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
VIATRIS HEALTHCARE (PTY) LTD,	SOUTH AFRICA	$1.6M	36
VIATRIS HEALTHCARE (PTY) LTD,'	SOUTH AFRICA	$300.0K	6
VIATRIS HEALTHCARE PTY LTD	SOUTH AFRICA	$250.0K	5
XXEMOXXCS XXTERXXTIOXXL IXX XX75 XXW JXXSEYXXVEN	UGANDA	$187.9K	4
XXATRXX HEXXTHCXXE (XXY) XXD XXMPTXX PAXX	SOUTH AFRICA	$161.9K	4
VIATRIS HEALTHCARE PTY LIMITED KEMPTON PARK	SOUTH AFRICA	$161.8K	4
XXA FXXNDAXXON XX O XXX 3XX98 X	UNITED ARAB EMIRATES	$148.1K	5
XXSOLXXIONXX POXXNERXXAN XX	TUNISIA	$138.6K	7
I SOLUTIONS POLANERBAAN 11	GHANA	$125.4K	3
XXEMOXXCS XXTERXXTIOXXL IXX 1XX5 NXX JEXXEY XXENU	CONGO	$100.0K	2

Mylan Laboratories Limited supplies Dolutegravir to 20 buyers globally. The largest buyer is VIATRIS HEALTHCARE (PTY) LTD, (SOUTH AFRICA), followed by VIATRIS HEALTHCARE (PTY) LTD,' (SOUTH AFRICA) and VIATRIS HEALTHCARE PTY LTD (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Dolutegravir Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
DOLUTEGRAVIR 10MG DISPERSIBLE TABLETS	$214.1K	9
DOLUTEGRAVIR DT 10MG 90BT	$200.0K	4
KAVIDEZA(ABACAVIR SULFATE 600MG + DOLUTEGRAVIR 50MG + LAMIVUDINE 300MG TAB 30S)(PACKS 30S BOTTLE) (27579 PACKS X 30NOS	$150.0K	3
KAVIDEZA(ABACAVIR SULFATE 600MG + DOLUTEGRAVIR 50MG + LAMIVUDINE 300MG TAB 30S)(PACKS 30S BOTTLE) (41215 PACKS X 30NOS	$150.0K	3
KAVIDEZA (ABACAVIR SULFATE 600MG +DOLUTEGRAVIR 50MG + LAMIVUDINE 300MG TAB 30'S) (PACKS : 30'S BOTTLE)(27555	$140.6K	3
KAVIDEZA (ABACAVIR SULFATE 600MG +DOLUTEGRAVIR 50MG + LAMIVUDINE 300MG TAB 30'S) (PACKS : 30'S BOTTLE)(27431	$140.4K	3
KAVIDEZA (ABACAVIR SULFATE 600MG +DOLUTEGRAVIR 50MG + LAMIVUDINE 300MG TAB 30'S) (PACKS : 30'S BOTTLE)(26978	$139.7K	3
KAVIDEZA (ABACAVIR SULFATE 600MG + DOLUTEGRAVIR 50MG + LAMIVUDINE 300MG TAB 30S) (PACKS 30S BOTTLE) (8522 PACKS X 30NOS	$139.7K	3
DOLUTEGRAVIR TAB 50MG 30BT	$136.1K	6
KAVMYL (ABACAVIR SULFATE 600MG + DOLUTEGRAVIR 50MG + LAMIVUDINE 300MG TAB 30'S) (PACKS : 30'S BOTTLE)(16470 P	$129.5K	3

Mylan Laboratories Limited exports 58 distinct Dolutegravir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOLUTEGRAVIR 10MG DISPERSIBLE TABLETS with 9 shipments worth $214.1K.

How Does Mylan Laboratories Limited Compare to Nearest Dolutegravir Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MACLEODS PHARMACEUTICALS LTD	$16.8M	336	67	$50.0K
8	MACLEODS PHARMACEUTICALS LIMITED	$6.7M	134	30	$50.0K
11	MYLAN LABORATORIES LIMITED ★	$5.5M	110	20	$50.0K
7	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$3.5M	69	14	$50.0K
6	APL HEALTHCARE LIMITED	$2.5M	51	9	$50.0K

Mylan Laboratories Limited ranks #11 among 104 Indian Dolutegravir exporters. Average shipment value of $50.0K compared to the market average of $1.4M. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and MACLEODS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Dolutegravir Exports?

Port	Shipments	% Share
SAHAR AIR	610	18.3%
NHAVA SHEVA SEA (INNSA1)	465	14.0%
JNPT/ NHAVA SHEVA SEA	316	9.5%
SAHAR AIR CARGO ACC (INBOM4)	284	8.5%
JNPT	180	5.4%
HYDERABAD ACC (INHYD4)	164	4.9%
HYDERABAD AIR	147	4.4%
DELHI AIR	137	4.1%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Dolutegravir Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Dolutegravir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 110 individual customs records matching Mylan Laboratories Limited exporting Dolutegravir, covering 58 formulations to 20 countries via 20 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 145+ countries, 592+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Dolutegravir

Dolutegravir

Mylan Laboratories Limited — Dolutegravir Exporter Profile

Mylan Laboratories Limited — Dolutegravir Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Dolutegravir?

Who Are the Top Buyers of Dolutegravir from Mylan Laboratories Limited?

What Is India's Total Dolutegravir Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Dolutegravir Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Dolutegravir Exporters?

What Dolutegravir Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Dolutegravir to Key Markets

South Africa — SAHPRA

How Does Mylan Laboratories Limited Compare to Nearest Dolutegravir Exporters?

Which Indian Ports Ship Dolutegravir Exports?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Dolutegravir Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Dolutegravir Export Data from Mylan Laboratories Limited

Dolutegravir Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source